* BIO-Key International Inc BKYI.OQ BKYI.O is expected
to show a rise in quarterly revenue when it reports results on
November 10 (estimated).
* The Wall Township, New Jersey-based company is expected to
report a 59.0% increase in revenue to $1.5 million from $943.33
thousand a year ago, according to the estimate from one analyst,
based on Refinitiv data.
* Refinitiv's mean analyst estimate for BIO-Key International
Inc is for a loss of 11 cents per share. For the same quarter
last year, the company reported a loss of 48 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in the
last three months.
* Wall Street's median 12-month price target for BIO-Key
International Inc is $6, about 47.7% above its last closing
price of $3.14.
* Previous quarterly performance (using preferred earnings
measure in US dollars).
QUARTER STARMINE REFINITIV ACTUAL BEAT, SURPRI
ENDING SMARTESTIM IBES MET, SE %
ATE® ESTIMATE MISSED
Jun. 30 2021 -0.11 -0.15 Missed -36.4
Mar. 31 2021 -0.16 -0.16 -0.09 Beat 43.8
Dec. 31 2020 -0.16 -0.18 Missed -12.5
Sep. 30 2020 -0.08 -0.08 -0.48 Missed -500
Jun. -0.24 -0.24 -0.56 Missed -133.3
30 2020
Mar. 31 2020 -0.40 -1.44 Missed -260
Dec. 31 2019 -0.24 -1.36 Missed -466.7
Sep. 30 2019 -0.40 -0.40 -1.04 Missed -160
This summary was machine generated November 8 at 17:27 GMT. All
figures in US dollars unless otherwise stated